Philip Marshall


Australia Member Since Jun 13, 2018

About Philip Marshall

Over 30 years experience in senior executive roles in pharma & biotech companies;
Founder & Director of global specialist consultancy firm to pharma;
Authorised Australia Govt. GMP Auditor;
Co-investor of ORIL’s chemistry patents

Companies & Work

Oncology Research International Ltd


ORIL is a public-unlisted biotech start-up headquartered in Adelaide, Australia; Founded by a cancer survivor, it has been carrying on the research work in low-cost & effective treatment of cancer based on chemical compounds found in natural recurring substance, using traditional Chinese medicine (TCM) approach; Currently the Company’s new chemical entity ORIL19 has been approved strong efficacy in curing liver & breasts cancer during pre-clinical research; the Company has been strongly encouraged & approved by US FDA to conduct clinical phase 1 research, but is in need of approx. AU$2-5m (US$1.5m) for funding the regulatory filing costs & ongoing research expenses


No education information added yet.

News & Press

No press / links added yet.

Community Discussions

Join Date

June 2018






Not Specified




Not Specified

Capital Eight is based in Australia

More People

Sam William

Sales Manager

Chris Alan


Bhuwan Dahal

Blogger/ Affiliate Marketer

Paul Williams

Manager Of PureLocal

Danilo Bonta

CEO of RECpitch

Nitin Mathew

Freelance Frontend Web Developer

BEAMSTART is a hub for everything Startups, Entrepreneurship, and Innovation. Connect with a global community of people, and stay updated with the latest news, events, and opportunities.


Download the Community App

Connect with the BEAMSTART Entrepreneurship Community from the palm of your hands. Connect with CEOs/Founders, Investors, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities:

PlayStore ButtonAppStore Button

© 2016 - 2022 BEAMSTART. All Rights Reserved (Legal).